Ccmd@lipo-apt

Intervention

1 paper4 findings

  • 1 lab in 1 country
  • Funders: Fujian Medical University and 1 more
  • Animals1

Outcomes

4

Apoptosis

upin mice1

1 study
  1. Ccmd@lipo-apt induces apoptosis in mice.

    Animalsalveolar epithelial type II cells

    Triple-pathway synergistic senolysis via AKAP1 silencing and calcium overload: An aptamer-functionalized DNAzyme nanoplatform for anti-pulmonary fibrosis research

    Colloids and surfaces. B, Biointerfaces26 Aug 2026

More on Apoptosis

Senescent alveolar epithelial type II cells

downin mice1

1 study
  1. Ccmd@lipo-apt decreases senescent alveolar epithelial type II cells in mice.

    Animalsin a bleomycin-induced mouse model

    Triple-pathway synergistic senolysis via AKAP1 silencing and calcium overload: An aptamer-functionalized DNAzyme nanoplatform for anti-pulmonary fibrosis research

    Colloids and surfaces. B, Biointerfaces26 Aug 2026

More on Senescent alveolar epithelial type II cells

Lung function

upin mice1

1 study
  1. Ccmd@lipo-apt improves lung function in mice.

    Animalsin a bleomycin-induced mouse model

    Triple-pathway synergistic senolysis via AKAP1 silencing and calcium overload: An aptamer-functionalized DNAzyme nanoplatform for anti-pulmonary fibrosis research

    Colloids and surfaces. B, Biointerfaces26 Aug 2026

Pulmonary fibrosis

downin mice1

1 study
  1. Ccmd@lipo-apt decreases pulmonary fibrosis in mice.

    Animalsin a bleomycin-induced mouse model

    Triple-pathway synergistic senolysis via AKAP1 silencing and calcium overload: An aptamer-functionalized DNAzyme nanoplatform for anti-pulmonary fibrosis research

    Colloids and surfaces. B, Biointerfaces26 Aug 2026

More on Pulmonary fibrosis

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 0Oct 2026: 01 in 12 months